| Name | 4-(5,7,7,10,10-Pentamethyl-2-nitro-7,8,9,10-tetrahydro-5H-benzo[b ]naphtho[2,3-e][1,4]diazepin-12-yl)benzoic acid |
|---|
| Description | HX531 is a potent RXR antagonist with an IC50 of 18 nM[1]. It has been shown to reduce triglyceride content in white adipose tissue, skeletal muscle, and the liver of mice on a high fat diet[2]. |
|---|---|
| Related Catalog | |
| Target |
RXR:18 nM (IC50) |
| References |
| Molecular Formula | C29H29N3O4 |
|---|---|
| Molecular Weight | 483.55800 |
| Exact Mass | 483.21600 |
| PSA | 98.72000 |
| LogP | 6.91620 |